Atlas Trials

Safety Study of Multiple-Vaccine to Treat Metastatic Breast Cancer

Clinical trial NCT01259505 · COMPLETED

Trial details

NCT number
NCT01259505
Sponsor
Tokyo Medical University
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Metastatic Breast Cancer
Start date
2009-12-01
Primary completion
2012-06-01
Enrollment
10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.